mantle cell lymphoma |
Disease ID | 27 |
---|---|
Disease | mantle cell lymphoma |
Manually Symptom | UMLS | Name(Total Manually Symptoms:16) C2364133 | infection C0334638 | multiple lymphomatous polyposis C0334108 | polyposis C0235618 | proliferative glomerulonephritis C0154254 | polyclonal hypergammaglobulinemia C0149937 | acute tubulo-interstitial nephritis C0043117 | idiopathic thrombocytopenic purpura (itp) C0043117 | idiopathic thrombocytopenic purpura C0037285 | skin manifestation C0037284 | skin lesions C0030805 | bullous pemphigoid C0024205 | lymphadenitis C0022660 | acute renal failure C0020625 | hyponatremia C0015300 | proptosis C0002880 | autoimmune haemolytic anaemia |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:6) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:7) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs113488022 | 25511147 | 673 | BRAF | umls:C0334634 | BeFree | The performance of the BRAF V600E-specific VE1 antibody was compared with that of allele-specific polymerase chain reaction (PCR) in 22 formalin-fixed, paraffin-embedded (FFPE) specimens with HCL involvement, along with nine splenic marginal zone lymphomas (SMZLs), 10 follicular lymphomas (FLs), 10 mantle cell lymphomas (MCLs), and 10 chronic lymphocytic leukemia/small lymphocytic lymphomas (CLL/SLLs). | 0.000271442 | 2015 | BRAF | 7 | 140753336 | A | T,G,C |
rs11547328 | 22592113 | 1019 | CDK4 | umls:C0334634 | BeFree | Recently two different mice models prone to develop MCL-like lymphomas were generated: c-myc-3'RR/Cdk4(R24C) mice and c-myc-3'RR/p53+/- mice. | 0.003810118 | 2012 | CDK4;MARCH9 | 12 | 57751648 | G | A |
rs121434221 | NA | 472 | ATM | umls:C0334634 | CLINVAR | NA | 0.246243163 | NA | ATM | 11 | 108329199 | A | G |
rs121434222 | NA | 472 | ATM | umls:C0334634 | CLINVAR | NA | 0.246243163 | NA | ATM | 11 | 108287687 | C | T |
rs1800629 | 20087644 | 7124 | TNF | umls:C0334634 | BeFree | TNF rs1800629 was associated with risk of NHL (OR 1.53, 95% confidence interval, CI, 1.06-2.19 for minor allele homozygosity), T-cell lymphoma (OR 2.54, CI 1.27-5.09) and mantle cell lymphoma (OR 2.84, CI 1.38-5.87). | 0.000271442 | 2010 | TNF | 6 | 31575254 | G | A |
rs1800890 | 20087644 | 3586 | IL10 | umls:C0334634 | BeFree | IL10 rs1800890 was associated with risk of diffuse large B-cell lymphoma (OR 1.41, CI 1.08-1.85 for minor allele homozygosity) and mantle cell lymphoma (OR 1.77, CI 1.04-3.00). | 0.000542884 | 2010 | IL10 | 1 | 206776020 | A | T |
rs796051857 | NA | 472 | ATM | umls:C0334634 | CLINVAR | NA | 0.246243163 | NA | ATM | 11 | 108329184 | - | GAA |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:1) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0001824 | Weight loss | MP:0001263 | weight loss; |
Mapped by homologous gene(Total Items:1) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0002716 | Lymphadenopathy | MP:0002420 | abnormal adaptive immunity;HP:0004377 | Hematological neoplasm |
Chemical(Total Drugs:7) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0334634 | amifostine | D004999 | 20537-88-6 | lymphoma, mantle-cell | MESH:D020522 | therapeutic | 11335791 | ||
C0334634 | arsenic trioxide | C006632 | 1327-53-3 | lymphoma, mantle-cell | MESH:D020522 | therapeutic | 23949314 | ||
C0334634 | bendamustine hydrochloride | D000069461 | - | lymphoma, mantle-cell | MESH:D020522 | therapeutic | 18980985 | ||
C0334634 | bortezomib | D000069286 | - | lymphoma, mantle-cell | MESH:D020522 | therapeutic | 16298074 | ||
C0334634 | mitoxantrone | D008942 | 65271-80-9 | lymphoma, mantle-cell | MESH:D020522 | therapeutic | 17228004 | ||
C0334634 | paclitaxel | D017239 | - | lymphoma, mantle-cell | MESH:D020522 | therapeutic | 7884419 | ||
C0334634 | temsirolimus | C401859 | - | lymphoma, mantle-cell | MESH:D020522 | therapeutic | 20828385 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |